Description

• Highly active against, multiple organisms including Staphylococcus
  aureus, Streptococcus pneumoniae, Haemophilus influenzae &
  Chlamydia trachomatis
• Exhibits greater acid stability compared to Erythromycin
• Possesses long half life leading to once daily dose convenience
• Achieves superior clinical cure rates compared to Clarithromycin
  in chronic bronchitis